Advancements in HCC Treatment

This chapter explores the progress in treating advanced Hepatocellular Carcinoma (HCC), from serafinib's historical introduction to new options like linvatinib and immunotherapy. It highlights key clinical trials that demonstrate improved survival rates and guides treatment decisions based on patient-specific factors.